We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hypoxia Factors Contribute to Maintenance of Regulatory T-cell Function

By LabMedica International staff writers
Posted on 29 Jun 2015
A team of cell biologists has identified a molecular pathway that maintains the stability and function of regulatory T-cells (Treg cells), which are components of the immune system that suppress immune responses of other cells and act as an important “self-check” built into the immune system to prevent excessive reactions.

Foxp3+ regulatory Treg cells play a critical role in immune homeostasis; however, the mechanisms to maintain their function have not been clarified. More...
In this regard, investigators at the La Jolla Institute for Allergy and Immunology (CA, USA) worked with a genetically engineered mouse model to determine how Treg function was maintained.

The mice were engineered to lack the gene that encodes the enzyme von Hippel-Lindau (VHL). Among the activities carried out by VHL is regulating hypoxia-inducible factor 1alpha (HIF-1alpha), an oxygen sensor that controls the expression of various genes for glucose metabolism under conditions of low oxygen levels.

The investigators reported in the June 16, 2015 online edition of the journal Immunity that the amount of HIF-1alpha within Treg cells lacking VHL increased sharply. In addition, the Treg cells became highly activated and produced large amounts of inflammatory cytokines, such as interferon-gamma (INF-gamma). HIF-1alpha knockdown or knockout could reverse the increased IFN-gamma production by VHL-deficient Treg cells and restore their suppressive function in vivo.

“Due to the inhibitory function of Treg cells, people have been trying to use these cells for therapy in human autoimmune diseases or transplantation,” said senior author Dr. Yun Cai Liu, professor of cell biology at the La Jolla Institute for Allergy and Immunology. “Our results suggest that these cells may not be stable, and, under certain conditions, may be even converted into inflammatory cells. Our studies imply that the change of oxygen levels in different tissues can be sensed by Treg cells and that this process is critically important for maintaining the correct balance between activation and suppression of the immune system.”

Related Links:

La Jolla Institute for Allergy and Immunology



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.